Optimizing Environmental Enrichment to Model Preclinical Neurorehabilitation
Project Number5R01NS084967-09
Former Number2R01NS084967-06
Contact PI/Project LeaderKLINE, ANTHONY E.
Awardee OrganizationUNIVERSITY OF PITTSBURGH AT PITTSBURGH
Description
Abstract Text
Traumatic brain injury (TBI) affects more than 10 million individuals worldwide each year (~ 2.8 million in the
USA) and results in long-term motor and cognitive deficits (e.g., reference learning and executive function). To
combat this significant health care issue a variety of relatively invasive experimental therapeutic strategies
have been attempted and have yielded limited translation to the clinic. Environmental enrichment (EE) is a
non-invasive paradigm that promotes significant cognitive recovery and histological protection after
experimental TBI and has the potential to mimic post-TBI clinical rehabilitation. The parent R01 was crafted to
begin refining and optimizing EE after TBI so that it conformed temporally to clinical neurorehabilitation. The
wealth of data lead to a preclinical model of neurorehabilitation that is temporally like the clinic in the sense that
delaying EE for a week (i.e., rehabilitation) and providing only 4-hr per day (as common in the clinic) shows
significant benefits. Overall, the findings provided significant support for EE as a potential model of
neurorehabilitation, but additional empirical research is essential to learn more about its capabilities and
limitations that ultimately strengthen its validity and applicability. Hence, the goal of this renewal is to utilize our
delayed (7 day) and abbreviated (4 h day) EE model of neurorehabilitation, which we refer to as Rehab, to
address questions that concern physiatrists. Five specific aims that are logical and crucial extensions of the
parent grant are proposed: Aim 1a determine whether motor (beam and rotarod), cognitive (spatial learning &
memory, and executive function using the attentional set shifting test that is analogous to the clinical Wisconsin
card sorting task), and affective (open field test) benefits can be sustained after EE is withdrawn, and if so, for
how long, Aim 1b determine if providing “refresher rehab” after the EE-induced benefits begin to wane will
stabilize or re-strengthen benefits, Aims 2abc determine whether “bridging” delayed EE, which is initiated at 7-
days after TBI, with a) [amantadine {10 mg/kg/day; i.p.}], b) aqua therapy [{two 90 s swim sessions}], or c)
music exposure [(3 h per night of New Age, Ambient, or Classical - Mozart’s sonata for two pianos,
K.448)] as adjunct therapies during the week after TBI will augment recovery relative to non-enriched or Rehab
groups, and Aim 3 evaluate mechanisms for the bridge plus Rehab therapies. Completion of the aims will
further advance a model of neurorehabilitation that mimics the real-world while addressing questions that
continue to concern physiatrists, such as how long do the rehab benefits last once discontinued and can they
be maintained or improved further with supplemental rehab? Can supplemental therapies before full rehab
provide a better outcome? What mechanisms are involved in the effects observed? The refined model will
significantly impact and advance rehabilitation-based research. Translatability of the findings will be facilitated
further by optimizing the EE model in adult rats of both sexes and by assessing behavior with sensitive and
clinically-relevant tests of motor and executive function both acutely and long-term.
Public Health Relevance Statement
Project Narrative
Traumatic brain injury (TBI) is a significant health care issue that affects 10 million individuals each year
throughout the world and about 2.8 million in United States for whom there are limited treatment options. While
numerous invasive therapies have been evaluated, one non-invasive approach that has clinical relevance is
environmental enrichment (EE), which is a therapeutic regimen that we have refined over the course of the
parent grant to mimic clinical rehabilitation and has been shown to provide significant benefits relative to non-
enriched housing. While EE is being optimized as a potential model of neurorehabilitation, additional empirical
research is essential to learn more about its capabilities and limitations that ultimately strengthen its validity
and applicability, and thus the goal of this renewal is to evaluate EE long-term, the effects of refresher
rehabilitation, and bridge therapies that robustly expand on the parent grant successes that will fill gaps and
expand our understanding of behavioral outcomes and mechanisms after TBI.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
004514360
UEI
MKAGLD59JRL1
Project Start Date
15-May-2014
Project End Date
30-June-2026
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$394,087
Direct Costs
$247,854
Indirect Costs
$146,233
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Neurological Disorders and Stroke
$394,087
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS084967-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS084967-09
Patents
No Patents information available for 5R01NS084967-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS084967-09
Clinical Studies
No Clinical Studies information available for 5R01NS084967-09
News and More
Related News Releases
No news release information available for 5R01NS084967-09
History
No Historical information available for 5R01NS084967-09
Similar Projects
No Similar Projects information available for 5R01NS084967-09